AzTrials
AzTrials

Medical DeviceSMART-METRONCT04668807

Technical Capabilities of the "SMART ANGEL Intra-hospital" System 's Connected Medical Device (CMD)

A study testing Connected Medical Device and Traditional transmission system in people with Medical Device, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Post-operative mortality in case of scheduled surgery is 3% in France (Lancet 2013) mainly due to cardiovascular or respiratory complications, by decompensation of pre-existing pathologies. Complications due to the medical practice are the third cause of morbidity(BMJ, 2016). Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Medical Device
What is being tested?
Connected Medical Device and Traditional transmission system
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteFrance
Study dates
Dec 2020to Jun 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age ≥ 18 years
  • Patients receiving a non-ambulatory surgical or interventional procedure lasting more than 2 hours
  • Affiliation with a social security syste, beneficiarie or eligible people (excluding State Medical Assistance (AME))
  • Written consent of the patient

Who cannot join

  • Patient carrying a multi-resistant germ and placed in isolation
  • Patient's known linguistic inability to understand the study
  • Non-ambulatory surgical or interventional act in an emergency situation
  • Patients under legal protection : curatorship or guardianship
  • Known pregnancy or nursing woman
  • Patients with implantable cardiac pacemakers, implantable defibrillators or neurostimulators

Trial locations and contacts

1 site in 1 country.

Jean-Louis MARTY, MD, PhD contact

01 49 81 43 45 ext. +33

jean.marty@aphp.fr

France1 site
  • Assistance Publique Hôpitaux de Paris - CHU Henri Mondor

    Créteil, 94 010

    Jean-Louis MARTY, MD, PhD, 01 49 81 43 45 ext. + 33, jean.marty@aphp.fr

Other trials in France

About this study

Official title: Assessment of the Technical Capabilities of the "SMART ANGEL" Intra-hospital System 's Connected Medical Device (CMD)

Post-operative mortality in case of scheduled surgery is 3% in France (Lancet 2013) mainly due to cardiovascular or respiratory complications, by decompensation of pre-existing pathologies.

Complications due to the medical practice are the third cause of morbidity(BMJ, 2016). More than half are preventable and are mainly observed in surgical patients. In conventional hospitalization, excluding intensive care, monitoring is done discontinuously for most of the patients, which does not allow early diagnosis of a vital cardiovascular or respiratory failure.

Diagnosis and late treatment do not allow good recovery. The early identification of a vital failure by the continuous monitoring of three simple physiological parameters (SpO2, heart rate and respiratory rate) would allow faster management by the hospital staff and a reduction in immediate and possibly delayed postoperative mortality.

Read the detailed description

The challenge of this research is to transpose in an ordinary hospitalization unit the continuous monitoring of vital functions carried out in intensive care by the continuous measurement of simple parameters using a Connected Medical Device (CMD).

Conditions
Medical Device
Being tested
Connected Medical Device, Traditional transmission system
Keywords
Connected Medical Device, Device Feasibility, Post-operative mortality, "SMART ANGEL intra-hospital" system

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Connected Medical DeviceDevice

    Monitoring of three simple physiological parameters (SpO2, heart rate and respiratory rate) with a Connected Medical Device (DMC) in the operating room

  • Traditional transmission systemDevice

    Monitoring of physiological parameters with a traditional wired transmission system between the sensor and the data processing device in the operating room

Study groups in NCT04668807
Study groupRoleWhat they receive
Connected Medical DeviceExperimental"SMART ANGEL Intra-hospital" System 's Connected Medical Device (DMC) measuring physiological parameters in the operating room
Receives: Device: Connected Medical Device
Traditional systemActive comparatorTraditional wired transmission system between the sensor and the data processing device in the operating room
Receives: Device: Traditional transmission system

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Agreement between the values measurements produced by the traditional monitoring system in the operating theater and the connected medical device of the "SMART ANGEL intra-hospital" system

    Measured: at 2 hours

Secondary outcomes (4)
  1. Evaluation of missing data due to device malfunction

    Measured: at 2 hours

  2. Nurse satisfaction (System Usability Scale)

    Measured: at 2 hours

  3. Occurrence of events during the course of the study

    Measured: at 2 hours

  4. Time needed by the nursing staff to set up the system

    Measured: at 2 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Dec 2020
  2. Study startDec 2020 (estimated)
  3. Primary completionJun 2021 (estimated)
  4. Study completionJun 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Device feasibility
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
Measurement of 3 constants (SpO2, heart rate and respiratory rate) in patients with a non-ambulatory surgical or interventional act lasting more than 2 hours whose constants are monitored by the reference device in the operating room and the Connected Medical Device.
Masking
None (open label)
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04668807
Sponsor's protocol ID
APHP190708
Other IDs
2019-A02197-50
Acronym
SMART-METRO
Status last verified
Feb 2020
First submitted
5 Nov 2020
Last updated
16 Dec 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Connected Medical Device and Traditional transmission system in people with Medical Device, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 16 Dec 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Jean-Louis MARTY, MD, PhD (01 49 81 43 45 ext. +33, jean.marty@aphp.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Agreement between the values measurements produced by the traditional monitoring system in the operating theater and the connected medical device of the "SMART ANGEL intra-hospital" system (time frame: at 2 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Dec 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in